FDA Investigates Global Recall System as Part of International Pivot

Drug Industry Daily
A A
SEATTLE — The FDA’s Office of International Programs (OIP) is exploring development of a single, global recall system that would encompass all domestic and international recalls.

To View This Article:

Login

Subscribe To Drug Industry Daily